Fisher Asset Management LLC reduced its position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report) by 2.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,825,644 shares of the company’s stock after selling 60,698 shares during the period. Fisher Asset Management LLC owned 25.23% of iShares U.S. Pharmaceuticals ETF worth $239,699,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Stratos Wealth Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $555,000. Accurate Wealth Management LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $6,372,000. D.A. Davidson & CO. acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $1,709,000. Childress Capital Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $1,018,000. Finally, Anfield Capital Management LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $10,007,000.
iShares U.S. Pharmaceuticals ETF Price Performance
Shares of iShares U.S. Pharmaceuticals ETF stock opened at $91.51 on Tuesday. iShares U.S. Pharmaceuticals ETF has a 12 month low of $63.03 and a 12 month high of $92.29. The business has a fifty day simple moving average of $87.17 and a 200 day simple moving average of $86.33. The stock has a market cap of $988.31 million, a PE ratio of 17.75 and a beta of 0.49.
iShares U.S. Pharmaceuticals ETF Profile
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
See Also
- Five stocks we like better than iShares U.S. Pharmaceuticals ETF
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Receive News & Ratings for iShares U.S. Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
